ArticlePharmaceutics2021

Overcoming MDR by Associating Doxorubicin and pH-Sensitive PLGA Nanoparticles Containing a Novel Organoselenium Compound-An In Vitro Study.

Letícia Bueno Macedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.